European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.68% to 1,973.64 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and biopharmaceutical company Grifols (GRFS), which advanced 24% and 5.6% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company argenx (ARGX), which rose 3.3% and 3% respectively.
The decliners from continental Europe were led by internet browser company Opera (OPRA) and biotech firm Evaxion (EVAX), which fell 7.9% and 6% respectively. They were followed by accommodations booking site Trivago (TRVG) and telecommunications company Nokia (NOK), which were down 4.3% and 1.6% respectively.
The gainers from the UK were led by biotech firm Autolus Therapeutics (AUTL) and mining company BHP Group (BHP), which increased 9.2% and 4.5% respectively. They were followed by software firm Endava (DAVA) and biopharmaceutical company Bicycle Therapeutics (BCYC), which were up 4% and 3.4% respectively.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which dropped 3.5% and 1.9% respectively. They were followed by insurance company Prudential (PUK) and medical device maker Smith & Nephew (SNN), which lost 1.3% and 1.1% respectively.